Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | May 20, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date May 20, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 46,226 |
Ending reported balance
After 2025-05-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-05-20 · Exercise / conversion · Acquired 454 · Balance 45,907 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 2 · 2025-05-20 · Exercise / conversion · Acquired 453 · Balance 46,360 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 3 · 2025-05-20 · Exercise / conversion · Acquired 572 · Balance 46,932 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 4 · 2025-05-21 · Sale · Disposed 706 · Balance 46,226 F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,614 |
Reported balance
After 2025-05-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-05-20 · Exercise / conversion · Disposed 454 · Balance 3,614 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,970 |
Reported balance
After 2025-05-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-20 · Exercise / conversion · Disposed 453 · Balance 9,970 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,488 |
Reported balance
After 2025-05-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-05-20 · Exercise / conversion · Disposed 572 · Balance 19,488 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,031,250 Underlying: Class A Common Stock · 22,917 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,125 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 581,538 Underlying: Class A Common Stock · 65,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,033,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,031,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,008,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 990,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 02, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 47,806 | $0.85 | $40,396.07 |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 925,400 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,050 Underlying: Class A Common Stock · 1,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,054,167 Underlying: Class A Common Stock · 22,917 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 616,250 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 646,986 Underlying: Class A Common Stock · 65,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 971,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 948,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 01, 2024 Filed May 6, 2024 16:55 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-014299 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 51,169 | $1.05 | $53,727.45 |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 865,079 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,685 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 22,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,077,084 Underlying: Class A Common Stock · 22,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,375 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712,436 Underlying: Class A Common Stock · 65,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 22,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 914,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 891,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 16:40 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-012486 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 873,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 16:58 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | GrantRestricted Stock Units · Derivative | 1,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-009220 · form4.xml · derivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Class A Common Stock · 1,100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments beginning on April 1, 2024. F2 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments beginning on April 1, 2024. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 38,826 | $1.26 | $48,765.46 |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 808,125 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,319 Underlying: Class A Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652,500 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,451 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 777,884 Underlying: Class A Common Stock · 65,451 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 846,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 17:08 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,451 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-008860 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 827,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 39,569 | $1.21 | $47,799.35 |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 761,737 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,957 Underlying: Class A Common Stock · 1,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,625 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,335 Underlying: Class A Common Stock · 65,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 801,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 17:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003588 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 781,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 45,794 | $1.54 | $70,522.76 |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716,098 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,639 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 633,592 Underlying: Class A Common Stock · 1,639 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,750 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · derivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908,783 Underlying: Class A Common Stock · 65,284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,639 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 761,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| January 02, 2024 Filed Jan 5, 2024 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,284 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-000975 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 742,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 42,402 | $1.39 | $58,811.57 |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 676,844 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 635,231 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F6 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 17:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-029012 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,875 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.